NCoR1 regulates thyroid hormone receptor isoform-dependent adipogenesis

Journal of Molecular Endocrinology

Volumn 46, Issue 3, 2011, Pages 233-244

  Zhu, Xu guang ^a   Kim, Dong Wook ^a   Goodson, Michael L ^b   Privalsky, Martin L ^b   Cheng, Sheue Yann ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; ISOPROTEIN; LIOTHYRONINE; MESSENGER RNA; NUCLEAR RECEPTOR COREPRESSOR; PROTEASOME; SMALL INTERFERING RNA; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR ALPHA1; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA1; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE MSIAH2; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN INTERACTION; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; DOWN-REGULATION; HUMANS; MICE; MUTATION; NUCLEAR RECEPTOR CO-REPRESSOR 1; PPAR GAMMA; PROMOTER REGIONS, GENETIC; PROTEIN INTERACTION MAPPING; PROTEIN ISOFORMS; RNA, SMALL INTERFERING; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONE RECEPTORS BETA; TIME FACTORS; TRANSCRIPTIONAL ACTIVATION; TRIIODOTHYRONINE; UBIQUITIN-PROTEIN LIGASES;

EID: 79959518563     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-10-0163     Document Type: Article

References (24)

1. Araki O, Ying H, Zhu XG, Willingham MC & Cheng SY 2009 Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. Molecular Endocrinology 23 308-315. (doi:10. 1210/me.2008-0311)
2. Astapova I, Dordek MF & Hollenberg AN 2009 The thyroid hormone receptor recruits NCoR via widely spaced receptor-interacting domains. Molecular and Cellular Endocrinology 307 83-88. (doi:10. 1016/j.mce.2009.02.028)
3. Bhat MK, McPhie P, Ting YT, Zhu XG & Cheng SY 1995 Structure of the carboxy-terminal region of thyroid hormone nuclear receptors and its possible role in hormone-dependent intermolecular interactions. Biochemistry 34 10591-10599. (doi:10.1021/ bi00033a034)
4. Cheng SY 2000 Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Reviews in Endocrine and Metabolic Disorders 1 9-18. (doi:10.1023/A:1010052101214)
5. Cohen RN, Brzostek S, Kim B, Chorev M, Wondisford FE & Hollenberg AN 2001 The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains. Molecular Endocrinology 15 1049-1061. (doi:10.1210/me.15.7.1049)
6. Furuya F, Guigon CJ, Zhao L, Lu C, Hanover JA & Cheng SY 2007 Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling. Molecular and Cellular Biology 27 6116-6126. (doi:10.1128/MCB.00900-07)
7. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK et al. 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377 397-404. (doi:10.1038/377397a0)
8. Kaneshige M, Kaneshige K, Zhu X, Dace A, Garrett L, Carter TA, Kazlauskaite R, Pankratz DG, Wynshaw-Boris A, Refetoff S et al. 2000 Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. PNAS 97 13209-13214. (doi:10.1073/pnas.230285997)
9. Kaneshige M, Suzuki H, Kaneshige K, Cheng J, Wimbrow H, Barlow C, Willingham MC & Cheng S 2001 A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice. PNAS 98 15095-15100. (doi:10.1073/pnas.261565798)
10. Liu YY, Schultz JJ & Brent GA 2003 A thyroid hormone receptor alpha gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice. Journal of Biological Chemistry 278 38913-38920. (doi:10.1074/jbc. M306120200)
11. Meier CA, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC, Menke JB, Hao EH, Usala SJ, Bercu BB et al. 1992 Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Molecular Endocrinology 6 248-258. (doi:10.1210/me.6.2.248)
12. Menendez-Hurtado A, Santos A & Perez-Castillo A 2000 Characterization of the promoter region of the rat CCAAT/enhancer-binding protein alpha gene and regulation by thyroid hormone in rat immortalized brown adipocytes. Endocrinology 141 4164-4170. (doi:10.1210/en.141.11.4164)
13. Mishra A, Zhu XG, Ge K & Cheng SY 2010 Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms. Journal of Molecular Endocrinology 44 247-255. (doi:10. 1677/JME-09-0137)
14. Parrilla R, Mixson AJ, McPherson JA, McClaskey JH & Weintraub BD 1991 Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. Journal of Clinical Investigation 88 2123-2130. (doi:10.1172/ JCI115542)
15. Perissi V, Jepsen K, Glass CK & Rosenfeld MG 2010 Deconstructing repression: evolving models of co-repressor action. Nature Reviews. Genetics 11 109-123. (doi:10.1038/nrg2736)
16. Rosen MD & Privalsky ML 2009 Thyroid hormone receptor mutations found in renal clear cell carcinomas alter corepressor release and reveal helix 12 as key determinant of corepressor specificity. Molecular Endocrinology 23 1183-1192. (doi:10.1210/me.2009-0126)
17. Sjogren M, Alkemade A, Mittag J, Nordstrom K, Katz A, Rozell B, Westerblad H, Arner A & Vennstrom B 2007 Hypermetabolism in mice caused by the central action of an unliganded thyroid hormone receptor alpha1. EMBO Journal 26 4535-4545. (doi:10. 1038/sj.emboj.7601882)
18. Ying H, Araki O, Furuya F, Kato Y & Cheng SY 2007 Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor. Molecular and Cellular Biology 27 2359-2371. (doi:10.1128/ MCB.02189-06)
19. Yoh SM & Privalsky ML 2000 Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor. Molecular and Cellular Endocrinology 159 109-124. (doi:10.1016/S0303-7207(99)00201-4)
20. Yoh SM, Chatterjee VK & Privalsky ML 1997 Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Molecular Endocrinology 11 470-480. (doi:10.1210/me.11.4.470)
21. Yu C, Markan K, Temple KA, Deplewski D, Brady MJ & Cohen RN 2005 The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis. Journal of Biological Chemistry 280 13600-13605. (doi:10.1074/jbc.M409468200)
22. Zhang J, Guenther MG, Carthew RW & Lazar MA 1998 Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes and Development 12 1775-1780. (doi:10.1101/gad.12.12.1775)
23. Zhang XY, Kaneshige M, Kamiya Y, Kaneshige K, McPhie P & Cheng SY 2002 Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant beta receptor. Molecular Endocrinology 16 2077-2092. (doi:10.1210/me.2002-0080)
24. Zhu X & Cheng SY 2010 New insights into regulation of lipid metabolism by thyroid hormone. Current Opinion in Endocrinology, Diabetes, and Obesity 17 408-413. (doi:10.1097/MED.0b013e32833d6d46)